Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Shengronghe Pharmaceutical is a Chinese pharmaceutical company based in Kunming, Yunnan Province, that specializes in the development, production, and sale of Traditional Chinese Medicine (TCM) and chemical generic drugs. The company's product portfolio includes a range of dosage forms such as large and small volume injections, tablets, capsules, and granules, primarily targeting cardiovascular diseases, respiratory conditions, and metabolic disorders. Notable products include Shengmai Injection and Metformin Hydrochloride tablets, which are distributed throughout the Chinese healthcare system. Shengronghe operates modern, GMP-certified manufacturing facilities and utilizes the diverse medicinal plant resources of the Yunnan region. The company is committed to modernizing traditional herbal remedies through rigorous quality control and advanced pharmaceutical technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Shengronghe Pharmaceutical.